Distribution of Dopamine Receptor 2 DRD2 rs1800497 Polymorphisms in Professional Football Players
Yıl: 2021 Cilt: 23 Sayı: 2 Sayfa Aralığı: 185 - 189 Metin Dili: İngilizce DOI: 10.15314/tsed.905202 İndeks Tarihi: 06-10-2022
Distribution of Dopamine Receptor 2 DRD2 rs1800497 Polymorphisms in Professional Football Players
Öz: According to the literature, the genetic makeup of athletes contributes to their athletic performance. Athletic performance depends on genetic and environmental factors relating to the athlete. The study of sports genetics includes extensive research into identifying genes that affect athletic performance. Psychological factors affect athletic performance and so dopamine contributes to the determination of that performance. One of the neurotransmitters of the dopaminergic system is dopamine, which affects the athlete mentally and psychologically. The dopamine receptor D2 (DRD2) rs1800497 polymorphism affects the brain’s dopaminergic system and athletic performance. This study aimed to determine the genotype and allele distributions of the DRD2 rs180047 polymorphism in football players and compare them with the control group. For this purpose, 21 football players were enrolled in our study. Genotyping was performed by PCR after DNAs were isolated from buccal epithelial cells. When we examined the genotype distributions, the AG and GG were found as 5 (24%) and 16 (76%), respectively. No AA genotype was found for DRD2. When allelic distributions were examined in the athlete group, the A allele was counted as 5 (12%) and the G allele as 37 (88%). In our study cohort, the DRD2 rs1800497 polymorphism was found to be dominated by the GG genotype and the G allele. We believe that the DRD2 A allele is associated with addiction and thus with athletic performance. However, more studies with athletes from different branches are needed to reveal the effect of DRD2 rs1800497 polymorphism on athletic performance.
Anahtar Kelime: Belge Türü: Makale Makale Türü: Araştırma Makalesi Erişim Türü: Erişime Açık
- 1. Abe D, Doi H, Asai T, Kimura M, Wada T, Takahashi Y, Matsumoto T, Shinohara K. Association between COMT Val158Met polymorphism and competition results of competitive swimmers. Journal of Sports Science and Medicine. 2017; 36(4): 393-397. doi: 10.1080/02640414.2017.1309058
- 2. Aslan BT, Eken BF, Kaman T, Sercan C, Ulucan K. Collagen type I alpha 1 (COL1A1) rs1800012 polymorphism in cyclists . Pamukkale Journal of Sport Sciences. 2020; 11(2): 1-4.
- 3. Berridge KC. Is Addiction a Brain Disease? Neuroethics. 2017; 10(1): 29–33. doi: 10.1007/s12152-016-9286-3
- 4. Bronikowski AM, Rhodes JS, Garland T Jr, Prolla TA, Awad TA, Gammie SC. The evolution of gene expression in mouse hippocampus in response to selective breeding for increased locomotor activity. Evolution. 2004;58(9): 2079-2086. doi: 10.1111/j.0014-3820.2004.tb00491.x.
- 5. Corak A, Kapıcı S, Sercan C, Akkoç O, Ulucan K. A pilot study for determination of anxiety related SLC6A4 promoter “S” and “L” alleles in healthy Turkish athletes. Cellular and Molecular Biology (Noisy-le-grand). 2017; 63(5): 29-31. doi: 10.14715/cmb/2017.63.5.6
- 6. De Moor MH, Liu YJ, Boomsma DI, Li J, Hamilton JJ, Hottenga JJ, Levy S, Liu XG, Pei YF, Posthuma D, Recker RR, Sullivan PF, Wang L, Willemsen G, Yan H, De Geus EJ, Deng HW. Genome-wide association study of exercise behavior in Dutch and American adults. Medicine & Science in Sports & Exercise. 2009;41(10): 1887-1895. doi: 10.1249/MSS.0b013e3181a2f646.
- 7. Drago J, Padungchaichot P, Accili D, Fuchs S. Dopamine receptors and dopamine transporter in brain function and addictive behaviors: insights from targeted mouse mutants. Developmental Neuroscience. 1998; 20: 188–203. doi: 10.1159/000017313
- 8. Eken BF, Akpınaroglu C, Arslan KS, Sercan C, Ulucan K. Effects of genes to psychological factors in sports. The Journal of Neurobehavioral Sciences. 2018; 5(1): 56–61. doi: 10.5455/JNBS.1516796381
- 9. Foley TE, Fleshner EM. Neuroplasticity of Dopamine Circuits After Exercise : Implications for Central Fatigue. NeuroMolecular Medicine. 2008; 10: 67–80. doi: 10.1007/s12017-008-8032-3
- 10. Gingrich JA, Caron MG. Recent advances in the molecular biology of dopamine receptors. The Annual Review of Neuroscience. 1993; 16: 299-321. doi: 10.1146/annurev.ne.16.030193.001503
- 11. Grandy DK, Litt M, Allen L, Bunzow JR, Marchionni M, Makam H, Reed L, Magenis RE, Civelli O. The human dopamine D2 receptor gene is located on chromosome 11 at q22-q23 and identifies a TaqI RFLP. American Journal of Human Genetics. 1989; 45(5): 778-785.
- 12. Hornykiewicz O. The action of dopamine on the arterial pressure of the guinea pig. The British Journal of Pharmacology. 1958; 13: 91- 94. doi: 10.1111/j.1476- 5381.1958.tb00197.x
- 13. Jaber M, Robinson SW, Missale C, Caron MG. Dopamine receptors and brain function. Neuropharmacology. 1996; 35: 1503–1519. doi: 10.1016/s0028-3908(96)00100-1
- 14. Jozkow P, Slowinska-Lisowska M, Laczmanski L, Medras M. DRD2 C313T and DRD4 48-bp VNTR polymorphisms and physical activity of healthy men in Lower Silesia, Poland (HALS study). Annals of Human Biology. 2013;40(2): 186-90. doi: 10.3109/03014460.2012.748829.
- 15. Kelly MA, Rubinstein M, Phillips TJ, Lessov CN, Burkhart- Kasch S, Zhang G, Bunzow JR, Fang Y, Gerhardt GA, Grandy DK, Low MJ. Locomotor activity in D2 dopamine receptor- deficient mice is determined by gene dosage, genetic background, and developmental adaptations. Journal of Neuroscience. 1998;18(9): 3470-3479. doi: 10.1523/JNEUROSCI.18-09-03470.1998.
- 16. Melis M, Greco B, Tonini R. Interplay between synaptic endocannabinoid signaling and metaplasticity in neuronal circuit function and dysfunction. European Journal of Neuroscience. 2014; 9: 1189–1201. doi: 10.1111/ejn.12501
- 17. Munafo MR, Matheson IJ, Flint J. Association of the DRD2 gene Taq1A polymorphism and alcoholism: a meta-analysis of case-control studies and evidence of publication bias. Molecular Psychiatry. 2007; 12: 454-461. doi: 10.1038/sj.mp.4001938
- 18. Ndamanisha JC, Guo L. Nonenzymatic glucose detection at ordered mesoporous carbon modified electrode. Biosensors and Bioelectronics. 2009; 23: 60- 63. doi: 10.1016/j.bioelechem.2009.05.003
- 19. Noble EP. Addiction and its reward process through polymorphisms of the D2 dopamine receptor gene: a review. European Psychiatry. 2000; 15: 79– 89. doi: 10.1016/s0924- 9338(00)00208-x
- 20. Özcan ÖÖ, Sercan C, Kulaksız H, Karahan M, Ulucan K. The Effect of Dopamin D2 Receptor TAQ A1 Allele on Sprinter and Endurance Athlete. International Journal of Medical. Medicine and Health Science. 2018; 12(9): 353-356. doi: 10.5281/zenodo.1474429
- 21. Thompson J, Thomas N, Singleton A, Piggott ML, loyd S, Perry EK, Morris CM, Perry RH, Ferrier IN, Court JA. D2 dopamine receptor gene (DRD2) taq1 A polymorphism reduced dopamine D2 receptor bindingin the human striatum associated with A1 allele. Pharmacogenetics. 1997; 7: 479-84. doi: 10.1097/00008571-199712000-00006
- 22. Turner E, Ewing J, Shilling P, Smith TL, Irwin M, Schuckit M, Kelsoe JR. Lack of association between an RFLP near the D2 dopamine receptor gene and severe alcoholism. Biological Psychiatry. 1992; 31(3): 285-290. doi: 10.1016/0006- 3223(92)90052-2
- 23. Pohjalainen T, Rinne JO, Någren K, Lehikoinen P, Anttila K, Syvälahti EKG, Hietala J. The A1 allele of the human D2 dopamine receptor gene predicts low D2 receptor availability in healthy volunteers. Molecular Psychiatry. 1998; 3: 256–260. doi: 10.1038/sj.mp.4000350
- 24. Polat T, Dogan CS, Dogan M, Akçay T, Ulucan K. Distribution of α actinin 3 rs1815739 and angiotensin 1 converting enzyme InDel polymorphisms in Turkish bodybuilders. Biomedical Reports. 2020; 13(6): 1–5. doi: 10.3892/br.2020.1374
- 25. Ulucan K. Literature review of Turkish sportsmen in terms of ACTN3 R577X polymorphism. Clinical and Experimental Health Sciences. 2016; 6: 44–47. doi: 10.5152/clinexphealthsci.2016.059
- 26. World Medical Association. World Medical Association Declaration of Helsinki: Ethical Principles for Medical Research Involving Human Subjects. JAMA. 2013; 310(20): 2191–2194. doi: 10.1001/jama.2013.281053
- 27. Yüksel İ, Kapıcı S, Sercan C, Kulaksız H, Polat T, Turan G, Ulucan K. Addiction Related DRD2 gene rs 1800497 polymorphism distribution in volleyball players and bodybuilders. The Journal of Neurobehavioral Sciences. 2017; 4(3): 122-125. doi: 10.5455/JNBS.1502377893
| APA | Tacal aslan B, Yılmaz Ö, Polat T, Şılar Ç, Eken B, sercan dogan c, Ulucan K (2021). Distribution of Dopamine Receptor 2 DRD2 rs1800497 Polymorphisms in Professional Football Players. , 185 - 189. 10.15314/tsed.905202 |
| Chicago | Tacal aslan Beste,Yılmaz Özlem Özge,Polat Tolga,Şılar Çisem,Eken Basak Funda,sercan dogan canan,Ulucan Korkut Distribution of Dopamine Receptor 2 DRD2 rs1800497 Polymorphisms in Professional Football Players. (2021): 185 - 189. 10.15314/tsed.905202 |
| MLA | Tacal aslan Beste,Yılmaz Özlem Özge,Polat Tolga,Şılar Çisem,Eken Basak Funda,sercan dogan canan,Ulucan Korkut Distribution of Dopamine Receptor 2 DRD2 rs1800497 Polymorphisms in Professional Football Players. , 2021, ss.185 - 189. 10.15314/tsed.905202 |
| AMA | Tacal aslan B,Yılmaz Ö,Polat T,Şılar Ç,Eken B,sercan dogan c,Ulucan K Distribution of Dopamine Receptor 2 DRD2 rs1800497 Polymorphisms in Professional Football Players. . 2021; 185 - 189. 10.15314/tsed.905202 |
| Vancouver | Tacal aslan B,Yılmaz Ö,Polat T,Şılar Ç,Eken B,sercan dogan c,Ulucan K Distribution of Dopamine Receptor 2 DRD2 rs1800497 Polymorphisms in Professional Football Players. . 2021; 185 - 189. 10.15314/tsed.905202 |
| IEEE | Tacal aslan B,Yılmaz Ö,Polat T,Şılar Ç,Eken B,sercan dogan c,Ulucan K "Distribution of Dopamine Receptor 2 DRD2 rs1800497 Polymorphisms in Professional Football Players." , ss.185 - 189, 2021. 10.15314/tsed.905202 |
| ISNAD | Tacal aslan, Beste vd. "Distribution of Dopamine Receptor 2 DRD2 rs1800497 Polymorphisms in Professional Football Players". (2021), 185-189. https://doi.org/10.15314/tsed.905202 |
| APA | Tacal aslan B, Yılmaz Ö, Polat T, Şılar Ç, Eken B, sercan dogan c, Ulucan K (2021). Distribution of Dopamine Receptor 2 DRD2 rs1800497 Polymorphisms in Professional Football Players. Türk Spor ve Egzersiz Dergisi, 23(2), 185 - 189. 10.15314/tsed.905202 |
| Chicago | Tacal aslan Beste,Yılmaz Özlem Özge,Polat Tolga,Şılar Çisem,Eken Basak Funda,sercan dogan canan,Ulucan Korkut Distribution of Dopamine Receptor 2 DRD2 rs1800497 Polymorphisms in Professional Football Players. Türk Spor ve Egzersiz Dergisi 23, no.2 (2021): 185 - 189. 10.15314/tsed.905202 |
| MLA | Tacal aslan Beste,Yılmaz Özlem Özge,Polat Tolga,Şılar Çisem,Eken Basak Funda,sercan dogan canan,Ulucan Korkut Distribution of Dopamine Receptor 2 DRD2 rs1800497 Polymorphisms in Professional Football Players. Türk Spor ve Egzersiz Dergisi, vol.23, no.2, 2021, ss.185 - 189. 10.15314/tsed.905202 |
| AMA | Tacal aslan B,Yılmaz Ö,Polat T,Şılar Ç,Eken B,sercan dogan c,Ulucan K Distribution of Dopamine Receptor 2 DRD2 rs1800497 Polymorphisms in Professional Football Players. Türk Spor ve Egzersiz Dergisi. 2021; 23(2): 185 - 189. 10.15314/tsed.905202 |
| Vancouver | Tacal aslan B,Yılmaz Ö,Polat T,Şılar Ç,Eken B,sercan dogan c,Ulucan K Distribution of Dopamine Receptor 2 DRD2 rs1800497 Polymorphisms in Professional Football Players. Türk Spor ve Egzersiz Dergisi. 2021; 23(2): 185 - 189. 10.15314/tsed.905202 |
| IEEE | Tacal aslan B,Yılmaz Ö,Polat T,Şılar Ç,Eken B,sercan dogan c,Ulucan K "Distribution of Dopamine Receptor 2 DRD2 rs1800497 Polymorphisms in Professional Football Players." Türk Spor ve Egzersiz Dergisi, 23, ss.185 - 189, 2021. 10.15314/tsed.905202 |
| ISNAD | Tacal aslan, Beste vd. "Distribution of Dopamine Receptor 2 DRD2 rs1800497 Polymorphisms in Professional Football Players". Türk Spor ve Egzersiz Dergisi 23/2 (2021), 185-189. https://doi.org/10.15314/tsed.905202 |
